These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3011261)

  • 41. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
    Malik ST; Rayner H; Fletcher J; Slevin ML
    Cancer Treat Rep; 1987 Dec; 71(12):1291-2. PubMed ID: 2825993
    [No Abstract]   [Full Text] [Related]  

  • 43. [Surgery in the multidisciplinary treatment of small-cell lung carcinoma].
    Maestu Maiques I; Pastor Borgoñón M; Aparicio Urtasun J; Gómez Codina J
    Rev Clin Esp; 1998 Nov; 198(11):752-7. PubMed ID: 9883050
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase II study of procarbazine in small cell carcinoma of the lung.
    Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(11-12):1099-1101. PubMed ID: 6271397
    [No Abstract]   [Full Text] [Related]  

  • 47. Mitomycin C in advanced cervical cancer.
    Tonusin A; Lorvidhaya V; Punpae P; Changwiwit W; Charoeniam V; Ployleumsang D; Issariyodom P
    J Med Assoc Thai; 1987 May; 70(5):275-9. PubMed ID: 2821141
    [No Abstract]   [Full Text] [Related]  

  • 48. A phase II trial of m-AMSA in patients with small-cell lung cancer.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytarabine: an inactive drug for extensive-stage small cell lung cancer.
    Stuart-Harris R; Bishop J; Raghavan D; Gianoutsos P; Lee J; Hillcoat B; Fox R
    Cancer Treat Rep; 1986 Feb; 70(2):303-4. PubMed ID: 3004728
    [No Abstract]   [Full Text] [Related]  

  • 51. Small cell (oat cell) undifferentiated lung carcinoma.
    Weiss RB; Jenkins JJ; Marano GD
    W V Med J; 1976 Sep; 72(9):254-62. PubMed ID: 184601
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 53. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
    Antman K; Pomfret E; Karp G; Skarin A; Canellos G
    Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
    [No Abstract]   [Full Text] [Related]  

  • 54. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
    Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase II trial of cisplatin in small cell carcinoma of the lung.
    Levenson RM; Ihde DC; Huberman MS; Cohen MH; Bunn PA; Minna JD
    Cancer Treat Rep; 1981; 65(9-10):905-7. PubMed ID: 6268297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous bone marrow transplantation in neoplasia.
    Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D; Jindal SK; Sharma SC
    Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A long-term survivor of extensive-stage small cell lung cancer].
    Seto T; Seto M; Ono K; Semba H; Kurano R
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):135-8. PubMed ID: 10660747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.